Buspirone Tolerability in an 83-Year-Old Mobile Elderly Patient
Buspirone is generally well tolerated in an 83-year-old mobile elderly patient, with safety and efficacy profiles similar to younger adults, and no age-related dose adjustments are required.
Evidence from FDA Labeling and Clinical Studies
The FDA label provides direct evidence that buspirone is safe in this age group. In a large study of 6,632 patients treated with buspirone for anxiety, 605 patients were ≥65 years old and 41 were ≥75 years old. The safety and efficacy profiles for these elderly patients (mean age 70.8 years) were similar to younger populations (mean age 43.3 years) 1. Importantly, age had no effect on the pharmacokinetics of buspirone, meaning the drug is processed similarly regardless of age 1.
Specific Tolerability Data in Elderly Patients
Multiple clinical trials confirm excellent tolerability:
In a multicenter trial of over 6,000 patients, 80% of elderly patients (≥65 years) reported no side effects, with a side effect profile nearly identical to younger patients 2
A controlled trial in patients over 65 years found buspirone at mean doses of 18 mg/day was well tolerated, even in patients taking multiple medications for chronic conditions (70% were on 2+ other drugs) 3
An 8-week randomized trial in elderly GAD patients showed no clinically significant adverse events with buspirone 10-15 mg/day 4
Key Advantages Over Benzodiazepines
This is particularly relevant given the 2019 AGS Beers Criteria, which strongly recommends avoiding benzodiazepines in older adults due to risks of cognitive impairment, falls, fractures, and dependence 5. Buspirone does not affect GABA-benzodiazepine receptors and therefore avoids these serious risks 1. The 2021 Mayo Clinic guidelines emphasize that safer alternatives to benzodiazepines should be pursued for anxiety in elderly patients 6, making buspirone an appropriate choice.
Important Caveats for Your 83-Year-Old Patient
Contraindications to Monitor:
- Severe hepatic or renal impairment: Buspirone cannot be recommended if present, as it increases plasma levels 13-fold (hepatic) or 4-fold (renal) 1. However, mild-moderate impairment is manageable with dose adjustment.
Practical Considerations:
- Start at standard adult doses (15 mg/day divided); no geriatric dose reduction needed 2, 3
- Takes 2-4 weeks for full anxiolytic effect 4
- Food increases bioavailability by 84% (AUC) and 116% (Cmax), so take consistently with or without food 1
- No increased fall risk or cognitive impairment compared to benzodiazepines
Mobility-Specific Note:
Since your patient is mobile, there's no concern about buspirone causing the mobility impairment, falls, or fractures associated with benzodiazepines 5. One small study in an 80-year-old with ataxia found buspirone was well tolerated without worsening gait 7.
Clinical Bottom Line
For an 83-year-old mobile patient, buspirone offers excellent tolerability with minimal age-related safety concerns, making it preferable to benzodiazepines for anxiety treatment 1, 2, 3. The main requirement is ensuring adequate hepatic and renal function before initiation.